Pune e (544141)
CyclicalScore breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹153.35 |
| Market Cap | ₹240.01 Cr |
| P/E Ratio | 22.99 |
| ROCE | 15.22% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -20.85% |
| Debt/Equity | — |
| Sales Growth | -34.55% |
| 52-Week Range | ₹180.5 — ₹333.95 |
| Sector | Capital Markets |
Strengths
- ROCE of 15.22% shows reasonably efficient capital deployment.
- Latest quarter net margin is high at roughly 38% (₹10 Cr net profit on ₹26 Cr sales).
- Company remains profitable despite the sharp revenue decline.
- Simple, understandable business model in stockbroking and allied services.
Concerns
- Sales down 34.55% and profit down 20.85%, indicating a shrinking business.
- Piotroski F-Score of 3/9 signals weak overall financial health.
- No dividend yield, so shareholders get no income while waiting for recovery.
- Lack of disclosed book value, ROE, and promoter holding limits analytical confidence.
AI Analysis
Pune e is a stockbroking firm, and I can understand that business. But understanding a business and loving its economics are different things. Stockbroking is intensely competitive, with low switching costs and earnings tied to market turnover. The figures reinforce that. Sales have fallen by 34.55% and net profit by 20.85%. That is not a compounding machine; that is a cyclical business in a downswing. The latest quarter, with ₹26 Cr revenue and ₹10 Cr profit, shows a high 38% net margin, but I do not pay for one season. The Piotroski F-Score of 3/9 tells me the financial health is weak, and there is no dividend to compensate me while I wait. At ₹153.35, the market cap is ₹240 Cr and the P/E is 22.99. That is not a bargain for a company whose earnings are shrinking. A Graham disciple demands a margin of safety, but here the safety is missing: book value, ROE and promoter holding are not disclosed, so I cannot judge asset backing or alignment with public shareholders. The share has fallen from ₹333.95, and I have learned that price declines do not automatically mean cheapness. I would not call this a stalwart. It is a cyclical, and until I see revenue stabilise, margins hold, and the F-score improve, the prudent action is to wait on the sidelines. My circle of competence will only expand when the numbers—and the management's candour—give me reason to be confident.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer